News

Tue 09 Aug 2022
Kantify in BX1 show on startups and Artificial Intelligence
Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence
Wed 20 Jul 2022
Fragile X Syndrome: Innovative Approaches to Finding a Cure
Join the talk of our CTO at this cornerstone online event of the Fragile-X patient and research communityt
Mon 30 May 2022
Targeted Protein Degradation : Kantify at Proteocure event
Kantify spoke about the latest progress of AI/ML for Degraders at the event of Proteocure
Mon 02 May 2022
Register to our webinar : Targeted Protein Degraders and AI
Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.
Sat 30 Apr 2022
Webinar replay : AI for in silico drug discovery
Watch the replay of our webinar on Zeptomics, Kantify solution for in silico drug discovery
Wed 27 Apr 2022
New discovery with I-Stem (Press Release)
Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease
Tue 19 Apr 2022
Pediatric acute lymphoblastic leukemia: New collaboration
In partnership with the Lyon University Hospital, Kantify is launching a project using Artificial Intelligence to identify leukemia cells (ALL)
Wed 13 Apr 2022
Abstract selected for Knowledge For Growth
The Abstract presents how AI can be used to accelerate and derisk lead optimization by predicting ADMET properties and off-target binding scores
Mon 28 Mar 2022
Kantify at the annual event of Brussels' Healthtech cluster
Kantify is speaking at the annual event of the Brussels cluster of healthtech companies
Tue 22 Mar 2022
Unveiling Zeptomics, Kantify’s AI drug discovery technology
Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery
Tue 15 Mar 2022
Kantify at the EU AI Week : #breakthebias
Kantify will be represented at the EU AI week event #breakthebias
Mon 10 Jan 2022
Kantify as a speaker on Life-on-Chip 2022
Join us at the Life-on-Chip conference where Kantify will speak about how artificial intelligence is used to accelerate diagnostics and drug discovery